Abstract
Aim
The aim of this study was to assess the Personalized Insomnia Intensity Goal (PIIG), the achievement of Personalized Goal Response (PGR), and Patient Global Impression (PGI) after a comprehensive symptom management.
Patients and methods
Advanced cancer patients admitted to palliative care units rated pain and symptoms intensity and their PIIG by using the Edmonton Symptom Assessment Score (ESAS) (T0). In patients with significant levels of insomnia, the achievement of target expected (PIIG) was measured (patient goal response, PIGR), as well the patient global impression (PGI), by the minimal clinically important difference (MCID), after a comprehensive symptom management (T7).
Results
Three hundred ninety-seven patients with a level of insomnia of ≥ 3 on ESAS were analyzed in this study. The mean values of PIIG at T0 and T7 were 1.2 (SD 1.5) and 0.9 (SD 1.4), respectively. Most patients (n = 406, 89.8%) indicated a PIIG of ≤ 3 as a target at T0. Such target was significantly lower at T7 (p = < 0.0005). PGI, expressed as MCID, was perceived with a mean decrease in insomnia intensity of − 2.3. In a minority of patients (n = 26; 5.8%) insomnia worsened, with a MCID of 0.50 (SD 2.8). Higher insomnia intensity at T0 and lower insomnia intensity at T7 were independently related to PGI. PIGR was achieved in 87.9% of patients. PIGR was associated with PIIG at T0, and inversely associated to insomnia intensity at T0 and T7, and PIIG at T7.
Conclusion
PGIR and PGI seem to be relevant for evaluating the effects of a comprehensive management of insomnia, suggesting therapeutic decisions according to PIIG. Some factors influencing the individual target and clinical response have been detected.
Similar content being viewed by others
References
Mercadante S, Aielli F, Adile C, Ferrera P, Valle A, Cartoni C, Pizzuto M, Caruselli A, Parsi R, Cortegiani A, Masedu F, Valenti M, Ficorella C, Porzio G (2015) Sleep disturbances in patients with advanced cancer in different palliative care settings. J Pain Symptom Manag 50:786–792
Sela RA, Watanabe S, Nekolaichuk CL (2005) Sleep disturbances in palliative cancer patients attending a pain and symptom control clinic. Palliat Support Care 3:23e31
Gibbins J, McCoubrie R, Kendrick AH et al (2009) Sleep-wake disturbances in patients with advanced cancer and their family carers. J Pain Symptom Manag 38:860e870
Mystakidou K, Parpa E, Tsilika E et al (2009) How is sleep quality affected by the psychological and symptom distress of advanced cancer patients? Palliat Med 23:46e53
George GC, Iwuanyanwu EC, Anderson KO, Yusuf A, Zinner RG, Piha-Paul SA, Tsimberidou AM, Naing A, Fu S, Janku F, Subbiah V, Cleeland CS, Mendoza TR, Hong DS (2016) Sleep quality and its association with fatigue, symptom burden, and mood in patients with advanced cancer in a clinic for early-phase oncology clinical trials. Cancer 122:3401–3409
Davies AN, Patel SD, Gregory A, Lee B (2017) Observational study of sleep disturbances in advanced cancer. BMJ Support Palliat Care 7:435–440
Mercadante S, Adile C, Ferrera P, Masedu F, Valenti M, Aielli F (2017) Sleep disturbances in advanced cancer patients admitted to a supportive/palliative care unit. Support Care Cancer 25:1301–1306
Delgado-Guay M, Yennurajalingam S, Parsons H, Palmer JL, Bruera E (2011) Association between self-reported sleep disturbance and other symptoms in patients with advanced cancer. J Pain Symptom Manag 41:819–827
Chang VT, Hwang SS, Feurman M (2000) Validation of the Edmonton symptom assessment scale. Cancer 88:2164–2171
Hui D, Bruera E (2017) The Edmonton symptom assessment system 25 years later: past, present, and future developments. J Pain Symptom Manag 53:630–643
Hannon B, Dyck M, Pope A, Swami N, Banerjee S, Mak E, Bryson J, Rodin G, Ridley J, Lo C, le LW, Zimmermann C (2015) Modified Edmonton symptom assessment system including constipation and sleep: validation in outpatients with cancer. J Pain Symptom Manag 49:945–952
Lydick E, Epstein R (1993) Interpretation of quality of life changes. Qual Life Res 2:221–226
Maringwa J, Quintien C, King M et al (2011) Minimal clinically meaningful differences for the EORTC QLQ-30 and EORTC QLQ-BN20 scales in brain cancer patients. Ann Oncol 22:2107–2112
Mercadante S, Adile C, Lanzetta G et al (2018) Personalized symptom goals and patient global impression on clinical changes in advanced cancer patients. Oncologist 16
Bedart G, Zeng L, Zhang L et al (2013) Minimal clinically important differences in the Edmonton symptom assessment system in patients with advanced cancer. J Pain Symptom Manag 46:192–200
Lauridsen HH, Hartvigsen J, Manniche C et al (1006) Responsiveness and minimal clinically important difference for pain and disability instruments in low back pain patients. BMC Musoclosklet Disrd 7:82
Hui D, Shamieh O, Paiva CE, Perez-Cruz PE, Kwon JH, Muckaden MA, Park M, Yennu S, Kang JH, Bruera E (2015) Minimal clinically important differences in the Edmonton symptom assessment scale in cancer patients: a prospective, multicenter study. Cancer 121:3027–3035
Dalal S, Hui D, Nguyen L, Chacko R, Scott C, Roberts L, Bruera E (2012) Achievement of personalized pain goal in cancer patients referred to a supportive care clinic at a comprehensive cancer center. Cancer 118:3869–3877
Mercadante S, Adile C, Ferrera P, Cortegiani A, Casuccio A (2017) Delirium assessed by memorial delirium assessment scale in advanced cancer patients admitted to an acute palliative/supportive care unit. Curr Med Res Opin 33:1303–1308
Hui D, Park M, Shamieh O, Paiva CE, Perez-Cruz PE, Muckaden MA, Bruera E (2016) Personalized symptom goals and response in patients with advanced cancer. Cancer 122:1774–1781
Yennurajalingam S, Balachandran D, Pedraza Cardozo SL, Berg EA, Chisholm GB, Reddy A, dela Cruz V, Williams JL, Bruera E (2017) Patient-reported sleep disturbance in advanced cancer: frequency, predictors and screening performance of the Edmonton symptom assessment system sleep item. BMJ Support Palliat Care 7:274–280
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Conflict of interest
The authors declare that they have no conflict of interest.
Additional information
Publisher’s note
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Rights and permissions
About this article
Cite this article
Mercadante, S., Adile, C., Aielli, F. et al. Personalized goal for insomnia and clinical response in advanced cancer patients. Support Care Cancer 28, 1089–1096 (2020). https://doi.org/10.1007/s00520-019-04912-z
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00520-019-04912-z